• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Tata Consultancy Services Ltd
Industry :  Computers - Software - Large
BSE Code
ISIN Demat
Book Value()
532540
INE467B01029
234.0734112
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TCS
15.46
832485.76
EPS(TTM)
Face Value()
Div & Yield %
148.84
1
4.78
 

Venus Remedies standalone net profit rises 193.78% in the March 2026 quarter
May 27,2026
Net profit of Venus Remedies rose 193.78% to Rs 43.45 crore in the quarter ended March 2026 as against Rs 14.79 crore during the previous quarter ended March 2025. Sales rose 31.65% to Rs 259.01 crore in the quarter ended March 2026 as against Rs 196.74 crore during the previous quarter ended March 2025.

For the full year,net profit rose 88.98% to Rs 99.31 crore in the year ended March 2026 as against Rs 52.55 crore during the previous year ended March 2025. Sales rose 19.28% to Rs 768.73 crore in the year ended March 2026 as against Rs 644.47 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales259.01196.74 32 768.73644.47 19
OPM %22.9512.83 -18.7211.64 -
PBDT64.0829.33 118 155.3790.77 71
PBT57.5724.84 132 130.6869.15 89
NP43.4514.79 194 99.3152.55 89